Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Müller-Schwefe

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
MMW Fortschritte Der Medizin|September 21, 2004
[Parental administration of flupirtine in musculoskeletal pain. Results of a postmarket surveillance study]G Müller-Schwefe
Journal of Neurosurgery|August 1, 1989
Physostigmine in the treatment of intrathecal baclofen overdose. Report of three casesG Müller-Schwefe, R D Penn
Schmerz (Berlin, Germany)|April 30, 2010
[Coding chronic pain in ICD-10]R-D Treede, G Müller-Schwefe, R Thoma
MMW Fortschritte Der Medizin|July 4, 2016
[Not Available]Roland Wörz, G Müller-Schwefe, I Stroehmann, et al.
MMW Fortschritte Der Medizin|March 15, 2000
[Back pain: guidelines for drug therapy. Utilize the therapeutic spectrum]R Wörz, G Müller-Schwefe, I Stroehmann, et al.
Journal of Clinical Medicine|March 14, 2026
Treatment Persistence in Migraine Prophylaxis Comparing CGRP Monoclonal Antibodies vs. High-/Low-Evidence Conventional Oral Preventives-A Comparative Real-World Evidence Study of Depersonalized Data of the German Pain e-RegistryMichael A Überall, Philipp C G Müller-Schwefe, Michael A Küster, et al.
Journal of Clinical Medicine|May 4, 2026
Self-Efficacy as a Central Mediator of Pain, Function, and Depression: Insights of a Cross-Sectional Analysis of Depersonalized Data from the German Pain e-RegistryMichael A Überall, Philipp C G Müller-Schwefe, Jan-Peter Jansen, et al.
Neurology|December 31, 1997
Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonusC Stayer, V Tronnier, J Dressnandt, et al.
European Neurology|July 9, 2004
Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptomsH C Diener, A Eikermann, U Gessner, et al.
Journal of Medical Economics|October 14, 2011
Healthcare utilization of back pain patients: results of a claims data analysisG Müller-Schwefe, A Freytag, A Höer, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
MMW Fortschritte Der Medizin|September 21, 2004
[Parental administration of flupirtine in musculoskeletal pain. Results of a postmarket surveillance study]G Müller-Schwefe
Journal of Neurosurgery|August 1, 1989
Physostigmine in the treatment of intrathecal baclofen overdose. Report of three casesG Müller-Schwefe, R D Penn
Schmerz (Berlin, Germany)|April 30, 2010
[Coding chronic pain in ICD-10]R-D Treede, G Müller-Schwefe, R Thoma
MMW Fortschritte Der Medizin|July 4, 2016
[Not Available]Roland Wörz, G Müller-Schwefe, I Stroehmann, et al.
MMW Fortschritte Der Medizin|March 15, 2000
[Back pain: guidelines for drug therapy. Utilize the therapeutic spectrum]R Wörz, G Müller-Schwefe, I Stroehmann, et al.
Journal of Clinical Medicine|March 14, 2026
Treatment Persistence in Migraine Prophylaxis Comparing CGRP Monoclonal Antibodies vs. High-/Low-Evidence Conventional Oral Preventives-A Comparative Real-World Evidence Study of Depersonalized Data of the German Pain e-RegistryMichael A Überall, Philipp C G Müller-Schwefe, Michael A Küster, et al.
Journal of Clinical Medicine|May 4, 2026
Self-Efficacy as a Central Mediator of Pain, Function, and Depression: Insights of a Cross-Sectional Analysis of Depersonalized Data from the German Pain e-RegistryMichael A Überall, Philipp C G Müller-Schwefe, Jan-Peter Jansen, et al.
Neurology|December 31, 1997
Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonusC Stayer, V Tronnier, J Dressnandt, et al.
European Neurology|July 9, 2004
Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptomsH C Diener, A Eikermann, U Gessner, et al.
Journal of Medical Economics|October 14, 2011
Healthcare utilization of back pain patients: results of a claims data analysisG Müller-Schwefe, A Freytag, A Höer, et al.
Pageof 2